Elicio Therapeutics, Inc entered into a Subscription Agreement and completed a private placement of 1,213,000 shares par value $0.01 per share, at a purchase price per Share of $5.81 for gross proceeds of $1,213,000 on December 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.4 USD | +0.97% | +9.47% | +24.70% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.70% | 95.87M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.39% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $7.04753 million in funding